Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Uniqure Ord Shs (NQ: QURE ) 7.580 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Uniqure Ord Shs < Previous 1 2 3 4 5 6 Next > uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for Fabry Disease November 29, 2023 Patient enrollment expected to begin in first half of 2024 From uniQure Inc. Via GlobeNewswire 3 Micro-Cap Stocks That Could Be Moonshots November 14, 2023 If you are hungry for high-risk returns, then these micro-cap stocks to buy could be your winning ticket to future yields. Via InvestorPlace uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress November 07, 2023 From uniQure Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday November 02, 2023 Pre-market stock movers are a hot topic on Thursday and we're checking out all of the biggest ones worth watching this morning! Via InvestorPlace Why Shares of uniQure Are Up Thursday October 05, 2023 The company announced a reorganization that included layoffs. Via The Motley Fool uniQure Announces Major Presence at the European Society of Gene and Cell Therapy (ESGCT) Annual Meeting October 24, 2023 From uniQure Inc. Via GlobeNewswire Gene Therapy Player UniQure To Lay Off 20% Of Workforce, Stop Parkinson's Study October 05, 2023 uniQure N.V. (NASDAQ: QURE) announced to cut about 20% of its total workforce, or about 114 jobs, and end investments in more than half of its research and technology Via Benzinga uniQure Announces Strategic Reorganization to Reduce Operating Expenses and Support Advancement of Multiple Clinical-Stage Programs October 05, 2023 From uniQure Inc. Via GlobeNewswire uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 02, 2023 From uniQure Inc. Via GlobeNewswire Why Shares of uniQure Are Dropping Tuesday September 05, 2023 The company is facing being delisted from the S&P 600 Index. Via The Motley Fool Topics Stocks Exposures US Equities Analyst Expectations for uniQure's Future August 02, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Monday October 02, 2023 On Monday, 369 companies set new 52-week lows. Via Benzinga Have Million-Dollar Gene Therapies Finally Reached An Inflection Point? September 15, 2023 Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions. Via Investor's Business Daily Exposures Product Safety Why uniQure Stock Cratered This Week June 22, 2023 An interim analysis for the company's Huntington's disease gene therapy wasn't a hit with investors. Via The Motley Fool Chardan Capital Maintains Buy Rating for uniQure: Here's What You Need To Know June 22, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday September 19, 2023 During Tuesday's session, 275 companies made new 52-week lows. Via Benzinga uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe Epilepsy September 05, 2023 Clinical trial initiation expected in the fourth quarter of 2023 From uniQure Inc. Via GlobeNewswire Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 05, 2023 Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform... Via Benzinga Airbnb, Blackstone Rise On News They'll Join S&P 500 Index September 02, 2023 ABNB and BX will join Sept. 18 as part of a quarterly rebalancing. Via Investor's Business Daily Topics Stocks Exposures US Equities 3 Tantalizing Stocks to Buy for Under $10 August 26, 2023 While investors should stick with the predictable ideas, those that want robust returns should target these stocks under $10 to buy. Via InvestorPlace uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress August 01, 2023 From uniQure Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday July 27, 2023 During Thursday, 56 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday July 26, 2023 Wednesday saw 59 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 25, 2023 On Tuesday, 56 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Monday July 24, 2023 On Monday morning, 70 companies achieved new lows for the year. Via Benzinga Stocks That Hit 52-Week Lows On Friday July 21, 2023 On Friday, 54 companies hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday July 20, 2023 During Thursday's session, 40 stocks hit new 52-week lows. Via Benzinga uniQure Announces Leadership Addition to Support Advancement of Clinical Programs June 26, 2023 ~ Walid Abi-Saab, M.D., appointed Chief Medical Officer, will bring extensive track record in leading drug development and execution ~ From uniQure Inc. Via GlobeNewswire INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against uniQure N.V. and Encourages Investors with Losses to Contact the Firm June 22, 2023 From The Schall Law Firm Via Business Wire Nordson To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Thursday June 22, 2023 Chardan Capital cut the price target for uniQure N.V. (NASDAQ: QURE) from $45 to $27. Chardan Capital analyst Matthew Barcus maintained a Buy rating. uniQure shares fell 1.5% to $11.45 in pre-market... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.